The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
Year: 2005
Type: article
Source: PubMed
Author: Boulos Haraoui
Institution: Université de Montréal
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2421311434
